WhichRecall
Class IIIReported 2026-01-21

Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC

Reason for Recall

Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.

Advertisement
Recall Number
D-0257-2026
Classification
Class III
Status
Ongoing
Category
drug
Initiated
2025-11-26
Reported
2026-01-21
Distribution
Nationwide in the USA.
Code Info
Lot#: AD30154, AD31143, AD31145, Exp 11/30/2025
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement